EUVIMEDEUVIMED entdecken
Open Access

Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer

Hsin-Yin Chuang iD, Da Huang iD, Lin Qi, Vidit Singh, Anna Chernatynskaya, Yue-Wern Huang iD, Hu Yang iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c03560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Hsin-Yin Chuang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri 65409, United States. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Dendrimers, Nanoparticles, Receptors, Urokinase Plasminogen Activator. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Missouri S&T Kummer Initiation Grant Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDendrimersNanoparticlesReceptors, Urokinase Plasminogen ActivatorRibonucleotide ReductasesAntineoplastic AgentsHumansAnimalsFemaleMiceCell Line, TumorMice, NudeGelsXenograft Model Antitumor Assays

Stichwörter der Autor:innen

activator receptorconfocal microscopynanomedicineribonucleotide reductasetargeted gene delivery

Substanzen

DendrimersReceptors, Urokinase Plasminogen ActivatorRibonucleotide ReductasesGelsAntineoplastic AgentsPAMAM Starburst

Autor:innen und Institutionen

  • Department of Biological Sciences, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
  • Linda and Bipin Doshi Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, Missouri 65409, United States.
  • College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, China.

ORCID-Profile: Hsin-Yin Chuang, Da Huang, Yue-Wern Huang, Hu Yang

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Missouri S&T Kummer Initiation Grant Initiative
  • Center for Biomedical Research (CBR) in S&T
  • Ozark Biomedical Initiative
  • John W. Claypool Fund for Medical Research

Zitieren

APA

Chuang, H. Y., Huang, D., Qi, L., Singh, V., Chernatynskaya, A., Huang, Y. W., & Yang, H. (2025). Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c03560

Vancouver

Chuang HY, Huang D, Qi L, Singh V, Chernatynskaya A, Huang YW, et al. Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c03560

BibTeX
@article{Chuang2025,
  author = {Chuang, Hsin-Yin and Huang, Da and Qi, Lin and Singh, Vidit and Chernatynskaya, Anna and Huang, Yue-Wern and Yang, Hu},
  title = {Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c03560}
}
Kostenlos starten →